Zim Laboratories (ZIMLAB) Share Price Falls 8.44% as Micro Cap Pharma Stock Slips to Rs 127

Zim Laboratories Share Price came under pressure today, with Zim Laboratories trading at Rs 127, down 8.44% from the previous close, while its market capitalisation stood at Rs 744.24 crore. Univest figures confirm the price action, but they do not point to a specific company trigger. For investors tracking Zim Laboratories Share Price Today, the move places ZIMLAB among the sharper declines in healthcare trade, even as the company remains a Micro Cap by market-cap category. The stock’s share price news matters because the fall occurred within a clearly defined intraday range, and the latest Univest figures also place the company in a valuation bucket that differs meaningfully from several larger pharma peers.

Zim Laboratories Share Price is relevant for readers searching Zim Laboratories Stock News, Zim Laboratories Share Price Fall and Zim Laboratories Share Price Live because the day’s move combines a lower trading level, a modest market capitalisation and a high earnings multiple. Univest data shows the stock is not just lower on the day; it is also trading well below the previous close, which makes the move a useful starting point for fundamental analysis and sector comparison.

Zim Laboratories (ZIMLAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 127
Previous Close	Rs 138.7
Today's Move	-Rs 11.70 (-8.44%)
Open	Rs 140.9
High	Rs 142.45
Low	Rs 126.95
Market Capitalisation	Rs 744.24 crore
Market Cap Category	Micro Cap

Zim Laboratories Share Price Today reflects a clear intraday decline. The stock last traded at Rs 127 versus a previous close of Rs 138.7, a fall of Rs 11.7 or 8.44%. It opened at Rs 140.9, touched a high of Rs 142.45 and a low of Rs 126.95, keeping the day’s range tight enough to show that the share price moved materially from its opening level during the ongoing session. Zim Laboratories Share Price therefore sits close to the lower end of the day’s range, which is an important price action detail for readers following Zim Laboratories Stock Falling Today.

The company’s market capitalisation of Rs 744.24 crore places it in the Micro Cap category, and that size context is relevant when interpreting Zim Laboratories Share Price Today alongside its intraday move. The stock’s latest trade near Rs 127 also makes the fall visible in percentage terms rather than only in rupee terms. For Zim Laboratories Share Price watchers, the key point is simple: the move is confirmed, the range is known and the decline is significant enough to draw attention in the broader Stock Market Today conversation. The next lens is fundamentals.

Zim Laboratories (ZIMLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 744.24 crore
P/E Ratio	201.36x
P/B Ratio	2.56x
ROE	2.14%
ROCE	5.47%
EPS	Rs 0.69
Book Value Per Share	Rs 54.16
Dividend Yield	0%

Zim Laboratories (ZIMLAB) fundamental metrics show P/E 201.36x, P/B 2.56x, ROE 2.14%, ROCE 5.47%. Taken on their own, these numbers offer context rather than a trading signal.

Zim Laboratories has a market capitalisation of Rs 744.24 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 201.36x, P/B at 2.56x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.14% and ROCE of 5.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.69, book value per share of Rs 54.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	201.36x
Benchmark Median P/E	31.73x
Benchmark Average P/E	45.98x
Benchmark P/E Range	3.1x to 616.89x
Company P/B Ratio	2.56x
Benchmark Median P/B	2.76x
Benchmark Average P/B	4.11x
Company ROE	2.14%
Benchmark Median ROE	11.33%
Benchmark Average ROE	10.14%
Company ROCE	5.47%
Benchmark Median ROCE	13.25%
Benchmark Average ROCE	13.05%
Company Market Capitalisation	Rs 744.24 crore
Benchmark Median Market Cap	Rs 771.43 crore
Benchmark Average Market Cap	Rs 13,467.03 crore

Zim Laboratories (ZIMLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Zim Laboratories (ZIMLAB) has a P/E ratio of 201.36x, which is above the benchmark median of 31.73x, a difference of +534.6%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Zim Laboratories (ZIMLAB) has a ROE of 2.14%, which is below the benchmark median of 11.33%, a difference of -81.11%. Zim Laboratories (ZIMLAB) has a ROCE of 5.47%, which is below the benchmark median of 13.25%, a difference of -58.72%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,18,683.95	34.61	4.84	14.85	19.11
Divi's Laboratories	DIVISLAB	2,41,310.94	82.5	13.66	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,73,078.79	79.36	19.28	26.76	19.27
Laurus Labs	LAURUSLABS	1,11,433.99	101.92	19.76	18.31	18.2
Zydus Lifesciences	ZYDUSLIFE	1,11,022.18	24.6	4.12	19.69	21.39

Zim Laboratories (ZIMLAB) has a P/E ratio of 201.36x compared with the displayed peer median of 79.36x. The comparison is relative and should not be read as a recommendation. Its ROE of 2.14% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 5.47% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Zim Laboratories (ZIMLAB) has a market capitalisation of Rs 744.24 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Zim Laboratories

• Zim Laboratories Share Price fell 8.44% to Rs 127, making the day’s decline a clear event for Stock News readers.
• The stock traded between Rs 126.95 and Rs 142.45, so Zim Laboratories Share Price Today had a defined intraday range.
• Market capitalisation of Rs 744.24 crore keeps Zim Laboratories in the Micro Cap category.
• P/E of 201.36 is far above the healthcare industry median of 31.73, which keeps Zim Laboratories Fundamental Analysis in focus.
• ROE of 2.14% and ROCE of 5.47% sit below the industry benchmark, adding context to Zim Laboratories Share Price Fall.

About Zim Laboratories

Zim Laboratories operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of the listed pharma set tracked on NSE and BSE, and Zim Laboratories Share Price reflects how the market is currently valuing that business profile. The latest Univest data identifies the company through its market-cap category and peer group, which places it among smaller listed pharmaceutical names rather than the large-cap drug makers. For readers following Zim Laboratories Stock News or Zim Laboratories Company News, the useful starting point is that the stock belongs to a sector where earnings multiples, return ratios and industry benchmarks vary widely across peers.

Track Zim Laboratories Share Price on Univest

Use Zim Laboratories (ZIMLAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Track Zim Laboratories Share Price on Univest for live share price updates, fundamental ratios, 52-week levels and market insights in one place. Univest also helps readers follow Zim Laboratories Share Price Today alongside valuation metrics such as P/E, P/B, ROE and ROCE, which are useful for stock analysis and sector comparison. If you are tracking Zim Laboratories Share News, the Univest stock page keeps the latest company context together.

Frequently Asked Questions

Why is Zim Laboratories Share Price falling today?

Ans. Zim Laboratories Share Price fell 8.44% to Rs 127 from Rs 138.7. Univest figures confirm the price action, but they do not point to a specific company trigger. The stock also traded within a clear intraday range.

What is Zim Laboratories Share Price Today?

Ans. Zim Laboratories Share Price Today is Rs 127. The stock was last traded below its previous close of Rs 138.7, and the day’s range extended from Rs 126.95 to Rs 142.45 during the ongoing session.

What is the market cap of Zim Laboratories?

Ans. Zim Laboratories has a market capitalisation of Rs 744.24 crore. According to Univest data, that places the company in the Micro Cap category, which is relevant when comparing Zim Laboratories Share Price with larger pharma peers.

How does Zim Laboratories compare with sector benchmarks?

Ans. Zim Laboratories Share Price carries a P/E of 201.36 versus the industry median of 31.73 and average of 45.98. Its ROE of 2.14% and ROCE of 5.47% are also below the same-industry benchmark.

What do EPS and book value mean for Zim Laboratories Share Price?

Ans. EPS is Rs 0.69, showing earnings attributable to each share. Book value is Rs 54.16 per share, which shows accounting net worth behind each share. These figures help frame Zim Laboratories Share Price alongside valuation ratios.

Does Zim Laboratories pay a dividend?

Ans. The dividend yield for Zim Laboratories is 0. That means the current Zim Laboratories Share Price does not carry a yield contribution in the latest Univest figures, so investors usually focus more on valuation and earnings ratios.

How did Zim Laboratories trade intraday?

Ans. Zim Laboratories opened at Rs 140.9, touched a high of Rs 142.45 and a low of Rs 126.95. The latest Zim Laboratories Share Price was Rs 127, which places it near the lower end of the day’s range.

Is Zim Laboratories expensive on earnings metrics?

Ans. Zim Laboratories Share Price trades on a P/E of 201.36, which is much higher than the healthcare industry median of 31.73. That makes the earnings multiple materially richer than the wider Pharmaceuticals & Drugs benchmark.

Where can I track Zim Laboratories Share Price on Univest?

Ans. You can track Zim Laboratories Share Price on Univest for live price updates, market-cap context, valuation ratios and sector comparisons. The same page also helps readers follow Zim Laboratories Stock News and fundamental analysis in one view.